GlobalData on MSN
Acesion begins patient enrolment in AP31969 Phase II AF study
The trial’s primary efficacy endpoint is AF burden, which refers to the percentage of time a participant is in AF.
DENVER, CO—The use of an implantable loop recorder (Reveal LINQ, Medtronic) identifies a high incidence of arrhythmic events at 12 months in patients who develop persistent left bundle branch block ...
August 14, 2003 — When evaluating select patients with recurrent unexplained syncope, a diagnostic strategy of prolonged primary monitoring using an implantable loop recorder is more cost effective ...
Please provide your email address to receive an email when new articles are posted on . The insertion of an implantable loop recorder in patients with systemic sclerosis and no known heart disease ...
May 10, 2005 (New Orleans) – Implantable loop recorders successfully provided a diagnosis in almost half of patients with unexplained syncope or presyncope, New York researchers reported at the Heart ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Implantable ...
Acesion Pharma ("Acesion" or "the Company"), a biotech company pioneering treatments for atrial fibrillation ("AF"), the most common cardiac arrhythmia, today announces enrolment of the first patients ...
The longer and continuous recording duration of an event loop recorder may offer physicians the advantage of recording paroxysmal and often silent episodes of atrial fibrillation that would not be ...
Using an implantable loop recorder (ILR) to screen older individuals for atrial fibrillation (AF) may be more beneficial when NT-proBNP levels are high, according to a post hoc analysis of the LOOP ...
Doctors at Columbus Community Hospital now have a high-tech new tool that can help them diagnose irregular heart rhythms that may not show up during standard testing. The tool, called a cardiac loop ...
Barcelona, Spain, 1 September 2009: The REVISE Study (Reveal in the Investigation of Syncope and Epilepsy) found that 1 in 8 adult patients in the United Kingdom, previously thought to be suffering ...
A UK cardiologist has become the first in the country to implant a hairpin-thin wireless heart monitor that routinely updates doctors on a patient's status. The Reveal LINQ device, engineered by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results